Extract from website at: http://www.cancercommons.org/researchers-clinicians/
CANCER COMMONS “is an open science initiative linking patients, physicians and scientists in rapid learning communities. Our mission is to ensure that patients are treated in accord with the latest knowledge on targeted- and immunotherapies, and to continually update that knowledge based on each patient’s response.”
Advisory boards, comprising leading physicians and scientists in each cancer, curate the molecular model that identifies the most relevant tests, treatments, and trials for each molecular sub type of that cancer, based on the best current knowledge.
Test and Treat
Patients and physicians access knowledge derived from the model, as soon as it’s deemed actionable, through alerts, notifications, news, and applications that inform testing and treatment decisions.
Report and Analyze
Physicians, researchers, and patients report clinical observations and outcomes and new data are analyzed in our Rapid Learning Communities by collaborative, interinstitutional teams to validate, refute, and amplify the current model’s knowledge and hypotheses.
The advisory boards review these results and update the framework in real time.